Document Detail


Feasibility and tolerability of transnasal/per-oral placement of the wireless pH capsule vs. traditional 24-h oesophageal pH monitoring--a randomized trial.
MedLine Citation:
PMID:  15679765     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: The wireless pH is a new technique to monitor oesophageal acid exposure. AIM: To compare the feasibility and tolerability of the wireless pH capsule vs. the traditional pH probe. METHODS: Consecutive patients referred for a pH test were enrolled into the study. Patients were randomized to traditional pH probe, or wireless pH capsule. Patients recorded their activities, food consumption, symptoms, satisfaction with the test and completed a quality of life questionnaire. RESULTS: Of the 50 patients recruited, 25 patients underwent placement of the traditional pH probe, and 25 the wireless pH capsule. Patients with the wireless pH capsule had less nose pain, runny nose, throat pain, throat discomfort and headache as compared with those with the traditional pH probe (P = 0.047, P = 0.001, P = 0.032, P = 0.001, P = 0.009, respectively). Patients in the wireless pH capsule group had more chest discomfort during the pH test (P = 0.037). Patients in the wireless pH capsule group perceived the test as interfering less with their overall daily activities, eating and sleep (P =0.001, P = 0.003, P = 0.025, respectively), and had overall satisfaction with the test (P = 0.023). CONCLUSIONS: Transnasal/per-oral placement of the wireless pH capsule is significantly better tolerated then the traditional pH probe.
Authors:
W-M Wong; J Bautista; R Dekel; I B Malagon; I Tuchinsky; C Green; R Dickman; R Esquivel; R Fass
Related Documents :
6533775 - Scintigraphy, radiography, and acid clearing in dysphagia patients after anti-reflux su...
23342555 - Dysregulation of histone deacetylase and histone acetyltransferase in development of we...
11093455 - Twenty-four hour intraesophageal ph monitoring in children and adolescents with sclerod...
8707075 - Effect of acute stress on oesophageal motility in patients with gastro-oesophageal refl...
21120485 - Serum levels of soluble cd163 in patients with systemic sclerosis.
22454415 - Marked, homogeneous, and early [18f]fluorodeoxyglucose-positron emission tomography res...
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Alimentary pharmacology & therapeutics     Volume:  21     ISSN:  0269-2813     ISO Abbreviation:  Aliment. Pharmacol. Ther.     Publication Date:  2005 Jan 
Date Detail:
Created Date:  2005-01-31     Completed Date:  2005-09-30     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8707234     Medline TA:  Aliment Pharmacol Ther     Country:  England    
Other Details:
Languages:  eng     Pagination:  155-63     Citation Subset:  IM    
Affiliation:
The Neuro-Enteric Clinical Research Group, Section of Gastroenterology, Department of Medicine, Southern Arizona VA Health Care System and University of Arizona Health Sciences Center, Tucson, AZ 85723, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Capsules
Circadian Rhythm
Esophagus / chemistry*
Feasibility Studies
Female
Gastric Acid / metabolism*
Gastroesophageal Reflux / physiopathology*
Humans
Hydrogen-Ion Concentration
Male
Middle Aged
Monitoring, Ambulatory / instrumentation*,  standards
Sleep / physiology
Chemical
Reg. No./Substance:
0/Capsules

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Rebound acid hypersecretion after long-term inhibition of gastric acid secretion.
Next Document:  Novel bismuth-metronidazole-tetracycline triple-layer tablet for treatment of Helicobacter pylori.